Skip to main content
GRCE $2.17 +0.93%
GRCE logo
GRCE · Grace Therapeutics, Inc.
Track GRCE — free
$2.17 +0.02 (+0.93%)
Market Cap
$46.28M
Shares
21.04M
All earnings calls

Earnings call · FY2022 Q2

Grace Therapeutics, Inc. (GRCE) Q2 2022 Earnings Call

Concluded Nov 10, 2021
Nov 10, 2021 0 turns
Period
FY2022 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Diluted EPS -$0.18
Net income $981,000

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document